1-216073333-AGG-AG
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_206933.4(USH2A):c.5573-34del variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.72 ( 39957 hom., cov: 0)
Exomes 𝑓: 0.71 ( 366519 hom. )
Consequence
USH2A
NM_206933.4 intron
NM_206933.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.879
Genes affected
USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
?
Variant 1-216073333-AG-A is Benign according to our data. Variant chr1-216073333-AG-A is described in ClinVar as [Benign]. Clinvar id is 1243806.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-216073333-AG-A is described in Lovd as [Benign].
BA1
?
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.921 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
USH2A | NM_206933.4 | c.5573-34del | intron_variant | ENST00000307340.8 | |||
USH2A-AS2 | NR_125992.1 | n.136+736del | intron_variant, non_coding_transcript_variant | ||||
USH2A-AS2 | NR_125993.1 | n.136+736del | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.5573-34del | intron_variant | 1 | NM_206933.4 | P1 | |||
USH2A-AS2 | ENST00000446411.5 | n.136+736del | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes ? AF: 0.723 AC: 109656AN: 151696Hom.: 39926 Cov.: 0
GnomAD3 genomes
?
AF:
AC:
109656
AN:
151696
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.734 AC: 176766AN: 240942Hom.: 65502 AF XY: 0.733 AC XY: 95387AN XY: 130108
GnomAD3 exomes
AF:
AC:
176766
AN:
240942
Hom.:
AF XY:
AC XY:
95387
AN XY:
130108
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.708 AC: 1029026AN: 1453250Hom.: 366519 Cov.: 0 AF XY: 0.710 AC XY: 513472AN XY: 722772
GnomAD4 exome
AF:
AC:
1029026
AN:
1453250
Hom.:
Cov.:
0
AF XY:
AC XY:
513472
AN XY:
722772
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.723 AC: 109735AN: 151814Hom.: 39957 Cov.: 0 AF XY: 0.724 AC XY: 53676AN XY: 74140
GnomAD4 genome
?
AF:
AC:
109735
AN:
151814
Hom.:
Cov.:
0
AF XY:
AC XY:
53676
AN XY:
74140
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2869
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Retinitis pigmentosa 39 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Usher syndrome type 2A Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at